Upstream Bio, Inc.

UPB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
Operating Activities
Net Income-$62,806-$20,537-$23,868
Dep. & Amort.$89$60$7
Deferred Tax$0$0$0
Stock-Based Comp.$6,004$3,427$1,279
Change in WC$1,873-$4,305$3,412
Other Non-Cash-$4,332-$16,571$149
Operating Cash Flow-$59,172-$37,926-$19,021
Investing Activities
PP&E Inv.-$511-$144-$82
Net Acquisitions$0$0$0
Inv. Purchases-$290,609-$128,990$0
Inv. Sales/Matur.$231,635$46,292$0
Other Inv. Act.$0$0$0
Investing Cash Flow-$59,485-$82,842-$82
Financing Activities
Debt Repay.$0$0$0
Stock Issued$272,723$129,550$9,963
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$146,187$129,550$9,963
Financing Cash Flow$418,910$129,550$9,963
Forex Effect$0$0$0
Net Chg. in Cash$300,253$8,782-$9,140
Supplemental Information
Beg. Cash$25,833$17,051$26,191
End Cash$326,086$25,833$17,051
Free Cash Flow-$59,683-$38,070-$19,103